| Last Action | 02/19/20: floor amendment (1) filed |
|---|---|
| Title | AN ACT relating to prescription insulin. |
| Bill Documents | Introduced |
| Bill Request Number | 1452 |
| Sponsor | R. Thomas |
| Summary of Original Version | Amend KRS 304-17A.148 to cap the cost-sharing requirements for prescription insulin at $100 per 30-day supply; EFFECTIVE January 1, 2021. |
| Index Headings of Original Version |
Drugs and Medicines - Prescription insulin drugs, cost sharing, cap Effective Dates, Delayed - Prescription insulin drugs, cost sharing, January 1, 2021 Insurance, Health - Prescription insulin drugs, cost sharing, cap |
| Jump to Proposed Amendments | Senate Floor Amendment 1 |
| 01/27/20 |
|
|---|---|
| 01/29/20 |
|
| 02/19/20 |
|
| Amendment | Senate Floor Amendment 1 |
|---|---|
| Sponsor | R. Thomas |
| Summary | Apply cost-sharing cap to diabetes testing supplies; effective January 1, 2021. |
| Index Headings |
Drugs and Medicines - Prescription insulin drugs, cost sharing, cap Effective Dates, Delayed - Prescription insulin drugs, cost sharing, January 1, 2021 Insurance, Health - Prescription insulin drugs, cost sharing, cap |
Last updated: 10/27/2020 12:10 PM (EDT)
To receive notice when the record is updated follow @LRCTweetBot. @LRCTweetBot